Blog > Editor's Pic > HSC takes 30% gains on Enzo Biochem (ENZ)
Share this article:
  • Print
  • Digg
  • del.icio.us
  • Facebook
  • Google Bookmarks
  • NewsVine
  • StumbleUpon
  • Twitter

HSC takes 30% gains on Enzo Biochem (ENZ)

Today's Financial News - Posted September 21, 2009

big-1.chartFall begins with a nice rise for TFN Hot Stock Confidential members… who chalked up double-digit gainer #62 for the year with Enzo Biochem (NYSE:ENZ).

by J. Christoph Amberger

Baltimore, MD — TFN: There’ll be some of you who will tell me I’m nuts. That Enzo Biochem, Inc. (NYSE:ENZ) is a great long-term hold: A biotech company that’s actually making money right now (as opposed to 5 years from now!) … and is likely to leverage innovation into greater market share.

I agree with you.

Two weeks ago, on September 10, I recommended our HSC Members “buy Enzo Biochem (NYSE:ENZ) below $5.50, with an expectation horizon of 20-30% by Summer 2010.”

Today, we’ve exceeded that projection. Today, Enzo was trading as high as $7.14 — even it’s dropped to $7.05. Our HSC Open Positions portfolio’s showing a 31% gain. If this were 2004 or even 2006, I’d say let’s take a long-term perspective and sit this one out for triple-digit gains.

But it’s 2009 — late September at that! This market is a rodeo… and no matter what I decide, I’m likely to look like a rodeo clown. I’d like to be a rodeo clown with a 30%-gain in my pocket.

If you want to hang on to the stock for the long term, please do so. Chances are we will catch up with you at a later point… because I think this stock has the hallmarks of a multi-play!

For the time being, sell Enzo Biochem (NYSE:ENZ) for gains of 30%-plus in 8 trading days.

This is double-digit gainer #62 so far this year for members of Hot Stock Confidential. Our 62 gainers and 13 losing trades average 22.2% — with an average holding period of 53 days.

Honestly, I think it’s high time you joined the club! (Do so at HotStockConfidential.com!)


Next Article: Oil investors: Keep your eye on that dollar

Posted by J. Christoph Amberger · Filed Under Editor's Pic 

Share this article:
  • Print
  • Digg
  • del.icio.us
  • Facebook
  • Google Bookmarks
  • NewsVine
  • StumbleUpon
  • Twitter

 Add to Technorati Favorites | Follow Us on Twitter!

Be the first to leave a reply.

Your comments are welcome